Inventor · disambiguated record
Charlotte Fieldhouse
Also filed as: FIELDHOUSE CHARLOTTE
14 granted patents·3 pending applications·45 citations·filing 2012–2024
90Inventor score
Files withTAKEDA PHARMACEUTICALS CO8FARNABY WILLIAM3HEPTARES THERAPEUTICS LTD2BROWN GILES ALBERT1NXERA PHARMA UK LTD1
Top patents by PatentIndex Score
17 records- 0195US11999745B2Pharmaceutical compoundsHEPTARES THERAPEUTICS LTD·Filed 2022·Granted Jun 4, 2024·3 cites·31 claims
- 0289US9156829B2Cycloalkyl and heterocycloalkyl compounds as orexin receptor antagonistsTAKEDA PHARMACEUTICAL·Filed 2015·Granted Oct 13, 2015·13 cites·20 claims
- 0386US10011588B21,2-substituted cyclopentanes as orexin receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jul 3, 2018·8 cites·18 claims
- 0484US11129828B2Pyridazinone compounds and their use as DAAO inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Sep 28, 2021·1 cites·10 claims
- 0580US9931340B2Pyridazinone compounds and their use as DAAO inhibitorsTAKEDA PHARMACUETICAL COMPANY LTD·Filed 2016·Granted Apr 3, 2018·4 cites·10 claims
- 0680US9290456B2Pyridazinone compounds and their use as DAAO inhibitorsFARNABY WILLIAM·Filed 2012·Granted Mar 22, 2016·4 cites·22 claims
- 0779US10689373B21,2-substituted cyclopentanes as orexin receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Jun 23, 2020·1 cites·19 claims
- 0879US9180122B25- or 6-substituted 3-hydroxy-2 (1 H)-pyridinones as D-amino acid oxidase (DAAO) inhibitors in therapy of diseases such as schizophrenia, cognitive disorder and painFARNABY WILLIAM·Filed 2012·Granted Nov 10, 2015·6 cites·28 claims
- 0978US12186313B2Pyridazinone compounds and their use as DAAO inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Jan 7, 2025·0 cites·10 claims
- 1077US10463663B2Pyridazinone compounds and their use as DAAO inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Nov 5, 2019·1 cites·16 claims
- 1175US2025115587A1Pyrazole derivatives as h4 antagonist compoundsBROWN GILES ALBERT·Filed 2024·Application pending·0 cites
- 1273US9790220B2Substituted cyclopentanes, tetrahydrofuranes and pyrrolidines as orexin receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Oct 17, 2017·2 cites·12 claims
- 1368US9750748B2Pyridazinones as DAAO enzyme inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2013·Granted Sep 5, 2017·1 cites·18 claims
- 1466US12234227B2Pyrazole derivatives as H4 antagonist compoundsNXERA PHARMA UK LTD·Filed 2019·Granted Feb 25, 2025·0 cites·17 claims
- 1566US9493432B2Cyclopentylbenzamide derivatives and their use for the treatment of psychotic and cognitive disordersTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Nov 15, 2016·1 cites·15 claims
- 1657US2013052281A1Novel compoundsFARNABY WILLIAM·Filed 2012·Application pending·0 cites
- 1754US2023167094A1H4 antagonist compoundsHEPTARES THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Charlotte Fieldhouse files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →